New substrates on the block: clinically relevant resistances for EmrE and homologues.
about
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Structural and mechanistic diversity of multidrug transporters.Efflux by small multidrug resistance proteins is inhibited by membrane-interactive helix-stapled peptides.Functional response of the small multidrug resistance protein EmrE to mutations in transmembrane helix 2.Extensive impact of non-antibiotic drugs on human gut bacteria.
P2860
New substrates on the block: clinically relevant resistances for EmrE and homologues.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
New substrates on the block: clinically relevant resistances for EmrE and homologues.
@ast
New substrates on the block: clinically relevant resistances for EmrE and homologues.
@en
type
label
New substrates on the block: clinically relevant resistances for EmrE and homologues.
@ast
New substrates on the block: clinically relevant resistances for EmrE and homologues.
@en
prefLabel
New substrates on the block: clinically relevant resistances for EmrE and homologues.
@ast
New substrates on the block: clinically relevant resistances for EmrE and homologues.
@en
P2860
P356
P1476
New substrates on the block: clinically relevant resistances for EmrE and homologues.
@en
P2093
Iris Nasie
Sonia Steiner-Mordoch
P2860
P304
P356
10.1128/JB.01318-12
P407
P577
2012-10-05T00:00:00Z